Literature DB >> 19113932

A simple risk score for the assessment of absolute fracture risk in general practice based on two longitudinal studies.

Saskia M F Pluijm1, Bart Koes, Chris de Laet, Natasja M Van Schoor, Natalia O Kuchuk, Fernando Rivadeneira, Johan P Mackenbach, Paul Lips, Huibert A Pols, Ewout W Steyerberg.   

Abstract

The aim of this prospective study was to develop a risk score, based on putative risk factors in current guidelines, which can be used to identify women at high risk of fractures in general practice. The study sample included 4157 women >/=60 yr of age (mean +/- SD: 74.1 +/- 9.1 yr), with a median follow-up of 8.9 yr of the Rotterdam Study (ERGO), and 762 women >/=65 yr of age (mean +/- SD: 76.0 +/- 6.7.yr), with a median follow-up of 6.0 yr of the Longitudinal Aging Study Amsterdam (LASA). Potential risk factors were those proposed in risk scores of three recent guidelines on osteoporosis: age, family history of fractures, prior fracture, low body weight/body mass index (BMI), serious immobility, rheumatoid arthritis, current smoking, alcohol consumption >2 units daily, prevalent vertebral fracture, and systemic corticosteroid use. Five-year absolute risk of hip fracture was 3.9% in the Rotterdam Study and 3.1% in LASA, and 10-yr absolute risk of hip fracture was 8.4% in the Rotterdam Study. Using Cox regression analysis, age (70-79 and 80+ versus <60-69) and four other risk factors were included in the risk profiles of hip fractures and fragility fractures: any prior fracture after age 50, body weight <64 kg, use of a walking aid as a proxy measure of serious immobility, and current smoking. Estimated 10-yr absolute risk of hip fracture ranged from 1.4% in women, age 60-69 years, without any of these predictors to 29% in women, >/=80 yr of age, having two or more positive risk factors. A simple risk score can satisfactorily identify older women at high risk of osteoporotic fractures in general practice. Future studies are needed to validate this score.

Entities:  

Mesh:

Year:  2009        PMID: 19113932     DOI: 10.1359/jbmr.081244

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  Alcohol consumption and hip fracture risk.

Authors:  X Zhang; Z Yu; M Yu; X Qu
Journal:  Osteoporos Int       Date:  2014-09-30       Impact factor: 4.507

2.  Competing mortality and fracture risk assessment.

Authors:  W D Leslie; L M Lix; X Wu
Journal:  Osteoporos Int       Date:  2012-06-27       Impact factor: 4.507

Review 3.  Glucocorticoid-induced bone fragility.

Authors:  Nancy E Lane; Wei Yao
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

4.  Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans.

Authors:  David L Kopperdahl; Thor Aspelund; Paul F Hoffmann; Sigurdur Sigurdsson; Kristin Siggeirsdottir; Tamara B Harris; Vilmundur Gudnason; Tony M Keaveny
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

5.  Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.

Authors:  Florence A Trémollieres; Jean-Michel Pouillès; Nicolas Drewniak; Jacques Laparra; Claude A Ribot; Patricia Dargent-Molina
Journal:  J Bone Miner Res       Date:  2010-05       Impact factor: 6.741

Review 6.  Comparison between various fracture risk assessment tools.

Authors:  W D Leslie; L M Lix
Journal:  Osteoporos Int       Date:  2014-01       Impact factor: 4.507

7.  Patient perceptions of osteoporosis treatment thresholds.

Authors:  Joan M Neuner; Marilyn M Schapira
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

Review 8.  Fracture risk assessment in postmenopausal women.

Authors:  Ronald C Hamdy
Journal:  Rev Endocr Metab Disord       Date:  2010-12       Impact factor: 6.514

9.  The utility and limitations of FRAX: A US perspective.

Authors:  Stuart L Silverman; Andrew D Calderon
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

10.  FRAX: Facts and Fantasy.

Authors:  Yashpal Gogate; Sanjay Kumar Bhadada
Journal:  Indian J Endocrinol Metab       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.